HOME RETURN TO PUBLIX.COM
Default content view for Magnesium

Nutritional Supplement

Magnesium

Also indexed as:Magnesium Oxide

Magnesium is an essential mineral to the human body. It is needed for bone, protein, and fatty acid formation, making new cells, activating B vitamins, relaxing muscles, clotting blood, and forming adenosine triphosphate (ATP), which is the energy the body runs on. The secretion and action of insulin also require magnesium.

References

1. Kostov K, Halacheva L. Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension. Int J Mol Sci 2018;19:1724.

2. Wu J, Xun P, Tang Q, et al. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Nutr J 2017;16:60.

3. Han H, Fang X, Wei X, et al. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J 2017;16:26.

4. Zhang X, Li Y, Del Gobbo LC, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension 2016;68:324–33.

5. Dibaba D, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2017;106:921–9.

6. Rosanoff A, Plesset MR. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis.Magnes Res. 2013;26:93–9.

7. Bashir Y, Sneddon JF, Staunton A, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993;72:1156-62.

8. Packer M, Gottlieb SS, Kessler PD. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Am J Med 1986;80 (Suppl 4A):23-9.

9. Galland LD, Baker SM, McLellan RK. Magnesium deficiency in the pathogenesis of mitral valve prolapse. Magnesium 1986;5:165-74.

10. Lichodziejewska B, Klos J, Rezler J, et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol 1997;79:768-72.

11. Bashir Y, Sneddon JF, Staunton A, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993;72:1156-62.

12. Tsuji H, Venditti FJ, Evans JC, et al. The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol 1994;74:232-5.

13. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium. Am J Cardiol 1990;65:1397-9 [review].

14. Brugada P. Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias. Eur Heart J 2000;21:1116 [review].

15. Durlach J. Neuromuscular and phlebothrombotic clinical aspects of primary magnesium deficiency. Z Ernahrungswiss 1975;14:75-83 [in French].

16. Martignoni E, Nappi G, Facchinetti F, Gennazzani AR. Magnesium in gynecological disorders. Gyn Endocrinol 1988;2(Suppl 2):26 [abstract].

17. Benassi L, Barletta FP, Baroncini L, et al. Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol 1992;19:176-9.

18. Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea. Schweiz Rundsch Med Prax 1990;79:491-4 [in German].

19. Seifert B, Wagler P, Dartsch S, et al. Magnesium—a new therapeutic alternative in primary dysmenorrhea. Zentralbl Gynakol 1989;111:755-60 [in German].

20. Ozcaliskan Ilkay H, Sahin H, Tanriverdi F, Samur G. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus. J Am Coll Nutr 2019;38:31–9.

21. Hruby A, Guasch-Ferre M, Bhupathiraju S, et al. Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts. Diabetes Care 2017;40:1695–702.

22. Chen S, Jin X, Liu J, et al. Association of Plasma Magnesium with Prediabetes and Type 2 Diabetes Mellitus in Adults. Sci Rep 2017;7:12763.

23. Fang X, Han H, Li M, et al. Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies. Nutrients 2016;8.

24. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci 2019;20.

25. Barbagallo M, Dominguez L. Magnesium and type 2 diabetes. World J Diabetes 2015;6:1152–7.

26. Kumar P, Bhargava S, Agarwal P, et al. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. J Family Med Prim Care 2019;8:1671–7.

27. Joy S, George T, Siddiqui K. Low magnesium level as an indicator of poor glycemic control in type 2 diabetic patients with complications. Diabetes Metab Syndr 2019;13:1303–7.

28. Zhang Q, Ji L, Zheng H, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2018;146:1–7.

29. Gant C, Soedamah-Muthu S, Binnenmars S, et al. Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes. Nutrients 2018;10.

30. Bherwani S, Jibhkate S, Saumya A, et al. Hypomagnesaemia: a modifiable risk factor of diabetic nephropathy. Horm Mol Biol Clin Investig 2017;29:79–84.

31. Dibaba D, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2017;106:921–9.

32. Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet 2017;30:621–33.

33. ELDerawi W, Naser I, Taleb M, Abutair A. The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients. Nutrients 2018;11.

34. Talari H, Zakizade M, Soleimani A, et al. Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2019;121:809–17.

35. Sadeghian M, Azadbakht L, Khalili N, et al. Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial. Biol Trace Elem Res 2019.

36. Durlach J. Neuromuscular and phlebothrombotic clinical aspects of primary magnesium deficiency. Z Ernahrungswiss 1975;14:75-83 [in French].

37. Martignoni E, Nappi G, Facchinetti F, Gennazzani AR. Magnesium in gynecological disorders. Gyn Endocrinol 1988;2(Suppl 2):26 [abstract].

38. Benassi L, Barletta FP, Baroncini L, et al. Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol 1992;19:176-9.

39. Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea. Schweiz Rundsch Med Prax 1990;79:491-4 [in German].

40. Seifert B, Wagler P, Dartsch S, et al. Magnesium—a new therapeutic alternative in primary dysmenorrhea. Zentralbl Gynakol 1989;111:755-60 [in German].

41. Gallai V, Sarchielli P, Coata G, et al. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache 1992;32:132-5.

42. Baker B. New research approach helps clarify magnesium/migraine link. Family Pract News 1993;Aug 15:16.

43. Barbiroli B, Lodi R, Cortelli P, et al. Low brain free magnesium in migraine and cluster headache: an interictal study by in vivo phosphorus magnetic resonance spectroscopy on 86 patients. Cephalalgia 1997;17:254.

44. Mazzotta G, Sarchielli P, Alberti A, Gallai V. Intracellular Mg++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia 1999;19:802-9.

45. Weaver K. Magnesium and migraine. Headache 1990;30:168 [letter].

46. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-63.

47. Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-301.

48. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 1996;16:436-40.

49. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci 1995;89:633-6.

50. Wynn A, Wynn M. Magnesium and other nutrient deficiencies as possible causes of hypertension and low birthweight. Nutr Health 1988;6:69-88.

51. Conradt A. Current concepts in the pathogenesis of gestosis with special reference to magnesium deficiency. Z Geburtshilfe Perinatol 1984;188:49-58 [review] [in German].

52. Leela R, Yasodhara P, Ramaraju MBBS, Ramaraju LA. Calcium and magnesium in pregnancy. Nutr Res 1991;11:1231-6.

53. Makrides M, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev 2000;2:CD000937 [review].

54. Li S, Tian H. Oral low-dose magnesium gluconate preventing pregnancy induced hypertension. Chung Hua Fu Chan Ko Tsa Chih 1997;32:613-5 [in Chinese].

55. D'Almeida A, Caretr JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992;19:117-31.

56. Bullarbo M, Odman N, Nestler A, et al. Magnesium supplementation to prevent high blood pressure in pregnancy: a randomised placebo control trial. Arch Gynecol Obstet 2013;288:1269–74.

57. Rudnicki M, Frolich A, Rasmussen WF, McNair P. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. A randomized double-blind placebo-controlled trial. Acta Obstet Gynecol Scand 1991;80:445-50.

58. Boschert S. Milk of magnesia may help ease urinary urge incontinence. Fam Pract News 2003;33:46.

59. Gordon D, Groutz A, Ascher-Landsberg J, et al. Double-blind, placebo-controlled study of magnesium hydroxide for treatment of sensory urgency and detrusor instability: preliminary results. Br J Obstet Gynaecol 1998;105:667-9.

60. Gaby, AR. Nutritional Medicine. Concord, NH: Fritz Perlberg Publishing, 2011.

61. Fox CH, Ramsoomair D, Mahoney MC, et al. An investigation of hypomagnesemia among ambulatory urban African Americans. J Fam Pract 1999;48:636-9.

62. Kisters K, Schodjaian K, Tokmak F, et al. Effect of ethanol on blood pressure—role of magnesium. Am J Hypertens 2000;13:455-6 [letter].

63. Weisinger JR, Bellorin-font E. Magnesium and phosphorus.Lancet 1998;352:391-6 [review].

Copyright © 2023 TraceGains, Inc. All Rights Reserved. Terms and Conditions TraceGains Accessibility